John Bradley Sorenson - 18 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
18 Feb 2025
Net transactions value
-$624,861
Form type
4
Filing time
19 Feb 2025, 16:23:50 UTC
Previous filing
18 Feb 2025
Next filing
06 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale $277,417 -2,657 -9.9% $104.41 24,294 18 Feb 2025 Direct F1
transaction BSX Common Stock Sale $347,443 -3,303 -14% $105.19 20,991 19 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.365, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.